Form D · Biotechnology

Spinal Balance, Inc.

Swanton, OH · CIK 0001658710

Offering snapshot reported Apr 29, 2020 · SEC filing

Reported sold
$4.29M
Offering amount: $5M
Investors reported
34
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Nov 10, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.15M$4.29MNov 18, 2015: $100,000.00Nov 18, 2015Jun 3, 2016: $500,000.00May 19, 2017: $600,000.00May 11, 2018: $2,840,300.00Nov 6, 2018: $3,090,300.00May 2, 2019: $3,740,300.00Aug 20, 2019: $3,990,300.00Apr 29, 2020: $4,290,300.00Apr 29, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,990,300 → $4,290,300
  • Reported investors31 → 34

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 29, 2020Amendment$4,290,300$300,000vs Aug 20, 201934SEC filing
Aug 20, 2019Amendment$3,990,300$250,000vs May 2, 201931SEC filing
May 2, 2019Amendment$3,740,300$650,000vs Nov 6, 201830SEC filing
Nov 6, 2018Amendment$3,090,300$250,000vs May 11, 201822SEC filing
May 11, 2018Amendment$2,840,300$2,240,300vs May 19, 201717SEC filing
May 19, 2017Amendment$600,000$100,000vs Jun 3, 20168SEC filing
Jun 3, 2016Amendment$500,000$400,000vs Nov 18, 20156SEC filing
Nov 18, 2015Initial$100,000No comparison1SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-251462

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
n/aNonen/a

Source: Form D, filed Apr 29, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anand K Agarwal Director, Executive
Vijay K Goel Director, Executive
Arthur Karas Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11360 South Airfield Road
Swanton, OH, 43558